Table 5.
Rate of augmentation with a second antipsychotic among patients discharged on clozapine and rate of SGAa augmentation among all augmentation patients, 2006–2017.
| Year | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
|---|---|---|---|---|---|---|
| No. of patients discharged on clozapine + a second antipsychotic (%) | 46 (19.1) | 70 (24.4) | 90 (28.0) | 104 (30.4) | 123 (33.9) | 121 (35.1) |
| No. of patients discharged on clozapine + a second SGAa (%) | 15 (32.6%) | 26 (37.1%) | 24 (26.7%) | 32 (30.8%) | 44 (35.8%) | 54 (44.6%) |
| No. of patients discharged on clozapine | 241 | 287 | 321 | 342 | 363 | 345 |
| Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|---|
| No. of patients discharged on clozapine + a second antipsychotic (%) | 107 (26.1) | 126 (31.9) | 146 (34.8) | 148 (42.8) | 151 (39.1) | 142 (36.2) |
| No. of patients discharged on clozapine + a second SGAb (%) | 54 (50.5%) | 66 (52.4%) | 76 (52.1%) | 86 (58.1%) | 98 (64.9%) | 93 (65.5%) |
| No. of patients discharged on clozapine | 410 | 395 | 420 | 346 | 386 | 392 |
aFGA = Firs-generation antipsychotic.
bSGA = Second-generation antipsychotic.